Literature DB >> 30279845

Percutaneous pulmonary debanding for an infant complicated by spontaneously closing muscular ventricular septal defect: A case report and in vitro study.

Atsushi Terazawa1, Takanari Fujii1, Takeshi Sasaki1, Dai Asada1, Suguru Tarui1, Yoshinori Miyahara1, Kozo Ishino1, Takashi Soga2, Hideshi Tomita1.   

Abstract

Pulmonary artery banding (PAB) is a standard operation for various congenital heart defects complicated by pulmonary hypertension (PH) and judged unsuitable for primary intracardiac repair. We report successful percutaneous pulmonary artery debanding in a baby complicated by muscular ventricular septal defect (VSD), that was initially large and multiple, but closed spontaneously later. The 5-month-old boy was referred to our hospital on day 3, diagnosed as having aortic coarctation (CoA), with multiple muscular VSDs and severe PH. On day 6, he underwent CoA repair and PAB using expanded polytetrafluoroethylene (ePTFE), while the muscular VSDs were left open. We planned percutaneous pulmonary debanding at the age of 5 months, as the muscular VSDs had become small. After dilation with a Mustang® (Boston Scientific, Marlborough, Massachusetts, United State) balloon (12 mm diameter) there was a persistent waist indicating a residual narrowing. Use of an extra-high pressure balloon, Conquest® (Medicon, Osaka, Japan) balloon of the same size, completely eliminated the waist. In in vitro experiments, the Mustang® partially tore the ePTFE, while a Conquest® of the same diameter completely opened the band. The mechanism of debanding was tearing of the ePTFE by the knot of the suture thread. Percutaneous pulmonary debanding to avoid unnecessary surgery is feasible in such a patient if the VSD becomes small. <Learning objective: Use of an extra-high pressure balloon, Conquest® (Medicon, Osaka, Japan) balloon could open the pulmonary artery banding made of expanded polytetrafluoroethylene (ePTFE). The mechanism of debanding was tearing of the ePTFE by the knot of the suture thread. Percutaneous pulmonary debanding to avoid unnecessary surgery is feasible in such a patient if the ventricular septal defect (VSD) becomes small.>.

Entities:  

Keywords:  Dacron® (Du Pont, Wilmington, Delaware, United States); Expanded polytetrafluoroethylene (ePTFE); Transcatheter pulmonary debanding; Ventricular septal defect

Year:  2017        PMID: 30279845      PMCID: PMC6149546          DOI: 10.1016/j.jccase.2017.08.012

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  4 in total

1.  Balloon debanding of the pulmonary artery.

Authors:  P G Bjørnstad; H L Lindberg; B Smevik; R Rian; S J Sørland; S Tjønneland
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Oct-Nov       Impact factor: 2.740

2.  Efficacy and safety of percutaneous transluminal balloon dilation to prevent progression of banding site stenosis after bilateral pulmonary artery banding.

Authors:  Shinsuke Hoshino; Masataka Kitano; Tadaaki Abe; Satoshi Yazaki; Koji Kagisaki
Journal:  Catheter Cardiovasc Interv       Date:  2015-02-25       Impact factor: 2.692

3.  Balloon debanding the pulmonary artery: in vitro studies and early clinical experience.

Authors:  Gareth J Morgan; Qiang Chen; Andrew Parry; Robin Martin
Journal:  Congenit Heart Dis       Date:  2009 Jul-Aug       Impact factor: 2.007

4.  Balloon dilatation of pulmonary artery banding: Norwegian experience over more than 20 years.

Authors:  Henrik Holmström; Per G Bjørnstad; Bjarne Smevik; Harald Lindberg
Journal:  Eur Heart J       Date:  2009-10-09       Impact factor: 29.983

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.